Page last updated: 2024-09-04

l 691121 and Myocardial Infarction

l 691121 has been researched along with Myocardial Infarction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appleby, SD; Baskin, EP; Bear, CM; Gehret, JR; Kothstein, T; Lynch, JJ; Sanguinetti, MC; Stupienski, RF; Van der Gaag, LH; Wallace, AA1

Other Studies

1 other study(ies) available for l 691121 and Myocardial Infarction

ArticleYear
Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 265, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Atrial Function; Cells, Cultured; Dogs; Electrophysiology; Ferrets; Guinea Pigs; Heart Atria; Heart Ventricles; In Vitro Techniques; Male; Myocardial Infarction; Myocardial Ischemia; Piperidones; Spiro Compounds; Ventricular Function

1993